Investigation of +405 and -460 polymorphisms of vascular endothelial growth factor in psoriasis and short-term responsiveness to efalizumab therapy

Dermatology. 2008;217(3):201-2. doi: 10.1159/000141651. Epub 2008 Jun 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Female
  • Humans
  • Male
  • Polymorphism, Single Nucleotide*
  • Psoriasis / drug therapy*
  • Vascular Endothelial Growth Factor A / genetics*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • efalizumab